Canada markets closed

Sinovac Biotech Ltd. (SVA)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
6.470.00 (0.00%)
At close: 04:00PM EDT
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-99,918
-99,918
113,866
8,467,480
110,369
Depreciation & amortization
144,745
144,745
156,597
86,832
4,037
Deferred income taxes
76,324
76,324
-83,010
265,096
-11,227
Stock based compensation
0
0
0
7,735
10,203
Change in working capital
277,906
277,906
-1,081,188
460,615
282,795
Accounts receivable
82,147
82,147
289,600
-710,355
-128,016
Inventory
-16,766
-16,766
30,382
-334,062
-77,738
Accounts Payable
109,430
109,430
-86,860
720,858
131,777
Other working capital
-41,691
-41,691
-1,174,113
14,632,564
351,659
Other non-cash items
-22,423
-22,423
-760
-725
-297
Net cash provided by operating activites
103,997
103,997
-770,745
15,352,541
479,309
Cash flows from investing activities
Investments in property, plant and equipment
-145,688
-145,688
-403,368
-719,977
-127,650
Acquisitions, net
-133,767
-133,767
-105,435
-13,663
0
Purchases of investments
-8,222,005
-8,222,005
-11,658,465
-8,826,611
-201,688
Sales/Maturities of investments
5,575,287
5,575,287
6,327,521
6,567,491
124,562
Other investing activites
-
-
-35,683
-30,986
-
Net cash used for investing activites
-2,924,113
-2,924,113
-5,760,470
-3,023,574
-204,756
Cash flows from financing activities
Debt repayment
-4,553
-4,553
-4,467
-46,768
-10,386
Common stock issued
676
676
0
1,033
1,999
Dividends Paid
-328,080
-328,080
-263,171
-1,875,892
0
Other financing activites
12,499
12,499
26,088
4,317
557,564
Net cash used privided by (used for) financing activities
-76,063
-76,063
-241,399
-1,896,680
592,566
Net change in cash
-3,011,080
-3,011,080
-7,333,383
10,569,556
894,326
Cash at beginning of period
4,286,377
4,286,377
11,619,760
1,050,204
155,878
Cash at end of period
1,275,297
1,275,297
4,286,377
11,619,760
1,050,204
Free Cash Flow
Operating Cash Flow
103,997
103,997
-770,745
15,352,541
479,309
Capital Expenditure
-145,688
-145,688
-403,368
-719,977
-127,650
Free Cash Flow
-41,691
-41,691
-1,174,113
14,632,564
351,659